NDTV Profit’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer NDTV Profit’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.
Motilal Oswal Report
Our recent interactions with Zen Technologies Ltd.'s management indicate that ordering in key areas of Zen will start ramping up in the coming months.
The company is also close to finalizing the plans for an inorganic acquisition for simulator or anti-drone business and is looking at the US as one of the key markets in the future.
Recently, Zen has signed an MoU with AVT Simulation, which is into air simulation systems, and Zen intends to complement its ground simulation system portfolio through this MoU.
Zen also expects improved traction in its recently launched products on remote-controlled weapon and battle surveillance systems.
We maintain our estimates and roll forward to Dec, 26 earnings and arrive at a revised target price of Rs 2,400 based on 40 times two-year forward earnings. Retain Buy.
Click on the attachment to read the full report:
DISCLAIMER
This report is authored by an external party. NDTV Profit does not vouch for the accuracy of its contents nor is responsible for them in any way. The contents of this section do not constitute investment advice. For that you must always consult an expert based on your individual needs. The views expressed in the report are that of the author entity and do not represent the views of NDTV Profit.
Users have no license to copy, modify, or distribute the content without permission of the Original Owner.
RECOMMENDED FOR YOU

'Buy' Kalyan Jewellers Shares, Maintains Motilal Oswal Post Inline Q1 Revenue — Check Target Price


Divi's Labs Q1 Review — Motilal Oswal Retains 'Neutral' Stance, Says Current Valuation Leaves Limited Upside


Power Grid Shares Is Still A 'Buy' For Motilal Oswal Despite Muted Q1 Performance — Check Target Price


Glenmark Arm IGI's AbbVie Deal Unfolds Blockbuster Potential, Says Motilal Oswal — Read Report
